54 related articles for article (PubMed ID: 24670859)
1. Reply to Letter: "Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable and Borderline Resectable Pancreatic Cancer".
Takahashi H; Ishikawa O
Ann Surg; 2015 Dec; 262(6):e103-4. PubMed ID: 24670859
[No Abstract] [Full Text] [Related]
2. Preoperative Gemcitabine-based Chemoradiation Therapy for Resectable and Borderline Resectable Pancreatic Cancer.
Ravikumar R; Fusai G
Ann Surg; 2015 Dec; 262(6):e103. PubMed ID: 24854654
[No Abstract] [Full Text] [Related]
3. Preoperative gemcitabine-based chemoradiation therapy for resectable and borderline resectable pancreatic cancer.
Takahashi H; Ohigashi H; Gotoh K; Marubashi S; Yamada T; Murata M; Ioka T; Uehara H; Yano M; Ishikawa O
Ann Surg; 2013 Dec; 258(6):1040-50. PubMed ID: 23799421
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of the serum CA19-9 level in "biological borderline resectability" and "biological downstaging" in the setting of preoperative chemoradiation therapy for pancreatic cancer.
Takahashi H; Yamada D; Asukai K; Wada H; Hasegawa S; Hara H; Shinno N; Ushigome H; Haraguchi N; Sugimura K; Yamamoto K; Nishimura J; Yasui M; Omori T; Miyata H; Ohue M; Yano M; Sakon M; Ishikawa O
Pancreatology; 2020 Jul; 20(5):919-928. PubMed ID: 32563596
[TBL] [Abstract][Full Text] [Related]
5. Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.
Stokes JB; Nolan NJ; Stelow EB; Walters DM; Weiss GR; de Lange EE; Rich TA; Adams RB; Bauer TW
Ann Surg Oncol; 2011 Mar; 18(3):619-27. PubMed ID: 21213060
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Gemcitabine-based Chemoradiation Therapy for Borderline Resectable Pancreatic Cancer: Impact of Venous and Arterial Involvement Status on Surgical Outcome and Pattern of Recurrence.
Takahashi H; Akita H; Tomokuni A; Kobayashi S; Ohigashi H; Fijiwara Y; Yano M; Sakon M; Ishikawa O
Ann Surg; 2016 Dec; 264(6):1091-1097. PubMed ID: 27462960
[TBL] [Abstract][Full Text] [Related]
7. Preoperative chemoradiation followed by surgical resection for resectable pancreatic cancer: a review of current results.
Chua TC; Saxena A
Surg Oncol; 2011 Dec; 20(4):e161-8. PubMed ID: 21704510
[TBL] [Abstract][Full Text] [Related]
8. In reply to Ren et al.
Passoni P; Reni M; Cattaneo GM; Slim N; Cereda S
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):431-2. PubMed ID: 24837892
[No Abstract] [Full Text] [Related]
9. Risk factors for vertebral compression fractures in preoperative chemoradiotherapy with gemcitabine for pancreatic cancer.
Otani K; Teshima T; Ito Y; Kawaguchi Y; Konishi K; Takahashi H; Ohigashi H; Oshima K; Araki N; Nishiyama K; Ishikawa O
Radiother Oncol; 2016 Mar; 118(3):424-9. PubMed ID: 26806264
[TBL] [Abstract][Full Text] [Related]
10. IMRT with capecitabine in advanced pancreatic cancer. In regard to Passoni et al.
Ren G; Xia T; Wang Y
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):431. PubMed ID: 24837893
[No Abstract] [Full Text] [Related]
11. [Chemoradiation therapy and immunotherapy for pancreatic cancer].
Egawa S; Motoi F; Fukuyama S; Sunamura M; Unno M
Nihon Rinsho; 2006 Jan; 64 Suppl 1():258-63. PubMed ID: 16457262
[No Abstract] [Full Text] [Related]
12. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
[TBL] [Abstract][Full Text] [Related]
13. [A Case of R0 Resection of Locally Advanced Pancreatic Cancer Following Chemoradiation Therapy].
Miyahara Y; Okamura D; Nishida T; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Takayashiki T; Kuboki S; Takano S; Suzuki D; Sakai N; Kagawa S; Miyazaki M
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2382-4. PubMed ID: 26805371
[TBL] [Abstract][Full Text] [Related]
14. An Unusual Gastric Lesion during Chemotherapy for Pancreatic Cancer.
Hattori A; Hamada Y; Kawabata H
Gastroenterology; 2020 Jul; 159(1):45-47. PubMed ID: 32205172
[No Abstract] [Full Text] [Related]
15. Preoperative Chemoradiation for Borderline Resectable Pancreatic Cancer: The New Standard?
Katz MH; Kim MP; Tzeng CW; Lee JE
Ann Surg; 2018 Aug; 268(2):223-224. PubMed ID: 29672417
[No Abstract] [Full Text] [Related]
16. [Recommendations for the management of pancreatic cancer type adenocarcinoma: A consensus statement reached during the 2015 Latin American Symposium on Gastroenterological Oncology].
Caglevic C; Gallardo J; de la Torre M; Mahave M; Müller B; Solé S; Moscoso Y; De La Fuente H; Roa JC; Hoefler S; Butte JM; González M P; O'Connor JM; Torres J; Pérez Encalada V; Alarcón Cano D; Ubillos L; Rolfo C; Lingua A; Díaz Romero C; Padilla Rosciano A; Cuartero V; Calderillo Ruiz G; Schwartsmann G; Kon Jara X; Andrade G A; Mas López L; Barajas O; Carballido M; Lembach H; Morillas G L; Roca E; Lobatón J; Montenegro B P; Yepes A; Marsiglia H
Rev Med Chil; 2016 Oct; 144(10):1305-1318. PubMed ID: 28074986
[TBL] [Abstract][Full Text] [Related]
17. [Gene therapy of human pancreatic cancer cells by human interferon-beta gene].
Nagata T; Endoh Y; Ohnishi Y; Yamagishi F; Tsukada K
Nihon Rinsho; 2006 Jan; 64 Suppl 1():228-31. PubMed ID: 16457256
[No Abstract] [Full Text] [Related]
18. [Chemoradiotherapy for pancreatic cancer].
Nakamura S
Nihon Shokakibyo Gakkai Zasshi; 2015 Dec; 112(12):2127-34. PubMed ID: 26638784
[No Abstract] [Full Text] [Related]
19. [Preoperative radiochemotherapy improves oncological results in borderline resectable pancreatic cancer, but not overall survival in resectable cancers : Results from the Dutch PREOPANC study].
Hermann RM; Christiansen H
Strahlenther Onkol; 2021 Jan; 197(1):85-88. PubMed ID: 33258046
[No Abstract] [Full Text] [Related]
20. Reply to the letter to the editor 'Borderline resectable pancreatic cancer: an evolving concept' by Petrucciani et al.
Gilbert JW; Wolpin B; Clancy T; Wang J; Mamon H; Shinagare AB; Jagannathan J; Rosenthal M
Ann Oncol; 2017 Sep; 28(9):2316. PubMed ID: 28541392
[No Abstract] [Full Text] [Related]
[Next] [New Search]
